Open Orphan - Confirmation of Hvivo acquisition
ORPH
Fri, 10 Jan 2020, 14:30 GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com
Cathal Friel, Chief Executive of Open Orphan, discusses the Hvivo acquisition and the management team of the group going into 2020.
